Furthermore, canine TK1-ELISA were developed by using the combination of peptide-based monopoly and poly-polyclonal dog TK1 antibodies for diagnosis and therapy monitoring of dog lymphomas (11, 12). This evidence concerns the gene TK1 and lymphoma.